Suppr超能文献

肝切除术对伴有肝外转移的肝细胞癌患者生存结局的影响:一项倾向评分匹配研究。

The impact of liver resection on survival outcomes of hepatocellular carcinoma patients with extrahepatic metastases: A propensity score matching study.

机构信息

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Department of Hepatobiliary Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.

Faculty of Medicine, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR, China.

出版信息

Cancer Med. 2018 Sep;7(9):4475-4484. doi: 10.1002/cam4.1738. Epub 2018 Aug 16.

Abstract

BACKGROUND

The majority of hepatocellular carcinoma patients (HCCs) with extrahepatic metastases die of progressive intrahepatic tumor. There have been little data on the role of primary tumor resection (PTR) for HCCs with extrahepatic metastases but with resectable primary tumors.

METHODS

A retrospective study was conducted on HCCs with extrahepatic metastases with resectable primary tumors who either underwent or did not undergo PTR in the SEER registry between 2004 and 2013. The overall and cancer-specific survivals (OS and CSS) were assessed by the log-rank test and the Cox proportional hazard regression model. A propensity score matching was conducted to minimize biases. Validation was performed in another cohort from the Sun Yat-sen Memorial Hospital (SYSMH).

RESULTS

Of the 529 HCCs with extrahepatic metastases with resectable primary tumors included into this study, 230 patients underwent PTR and 299 did not. The percentages of patients who underwent PTR increased from 38.6% in 2004 to 70.3% in 2013. In the propensity score-matched patients, PTR was associated with improved OS (HR 0.310, P < 0.001) and CSS (HR 0.326, P <0.001). These improvements in survivals remained significant after sensitivity analyses using multiple imputation. In the validation cohort from the SYSMH (n = 131), PTR was also correlated with improved OS (HR 0.508, P = 0.002) and CSS (HR 0.568, P = 0.017).

CONCLUSIONS

This study using propensity score matching and multiple imputation demonstrated that PTR had a favorable impact on the prognosis of HCCs with extrahepatic metastases with resectable primary tumors. Further prospective randomized trials are needed to confirm these findings.

摘要

背景

大多数患有肝外转移的肝细胞癌(HCC)患者死于进行性肝内肿瘤。对于肝外转移但可切除原发肿瘤的 HCC 患者,原发肿瘤切除术(PTR)的作用鲜有数据报道。

方法

本研究对 2004 年至 2013 年间 SEER 注册中心中接受或未接受 PTR 的肝外转移且可切除原发肿瘤的 HCC 患者进行了回顾性研究。采用对数秩检验和 Cox 比例风险回归模型评估总生存期(OS)和癌症特异性生存期(CSS)。采用倾向评分匹配法以尽量减少偏倚。并在中山大学附属肿瘤医院(SYSMH)的另一队列中进行了验证。

结果

本研究共纳入 529 例肝外转移且可切除原发肿瘤的 HCC 患者,其中 230 例患者接受了 PTR,299 例患者未接受。接受 PTR 的患者比例从 2004 年的 38.6%增加到 2013 年的 70.3%。在倾向评分匹配的患者中,PTR 与改善 OS(HR 0.310,P<0.001)和 CSS(HR 0.326,P<0.001)相关。在使用多重插补的敏感性分析中,这些生存获益仍然显著。在 SYSMH 的验证队列(n=131)中,PTR 也与改善 OS(HR 0.508,P=0.002)和 CSS(HR 0.568,P=0.017)相关。

结论

本研究采用倾向评分匹配和多重插补法表明,PTR 对可切除原发肿瘤的肝外转移 HCC 患者的预后有积极影响。需要进一步的前瞻性随机试验来证实这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fbb/6143947/f60d27089301/CAM4-7-4475-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验